These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35222525)

  • 21. A novel oxidative stress-related genes signature associated with clinical prognosis and immunotherapy responses in clear cell renal cell carcinoma.
    Wu X; Li F; Xie W; Gong B; Fu B; Chen W; Zhou L; Luo L
    Front Oncol; 2023; 13():1184841. PubMed ID: 37601683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma.
    Xing Q; Zeng T; Liu S; Cheng H; Ma L; Wang Y
    BMC Cancer; 2021 Apr; 21(1):381. PubMed ID: 33836688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a novel immune-related microRNA prognostic model in clear cell renal cell carcinoma.
    Guo Y; Li X; Zheng J; Fang J; Pan G; Chen Z
    Transl Androl Urol; 2021 Feb; 10(2):888-899. PubMed ID: 33718090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a three-miRNA signature as a novel potential prognostic biomarker in patients with clear cell renal cell carcinoma.
    Luo Y; Chen L; Wang G; Xiao Y; Ju L; Wang X
    J Cell Biochem; 2019 Aug; 120(8):13751-13764. PubMed ID: 30957284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A newly defined basement membrane-related gene signature for the prognosis of clear-cell renal cell carcinoma.
    Zhou T; Chen W; Wu Z; Cai J; Zhou C
    Front Genet; 2022; 13():994208. PubMed ID: 36186476
    [No Abstract]   [Full Text] [Related]  

  • 26. Construction and Validation of Protein Expression-related Prognostic Models in Clear Cell Renal Cell Carcinoma.
    Ma X; Sun L
    J Cancer; 2023; 14(5):793-808. PubMed ID: 37056387
    [No Abstract]   [Full Text] [Related]  

  • 27. A Novel Immune-Related Prognostic Signature for Thyroid Carcinoma.
    Xue Y; Li J; Lu X
    Technol Cancer Res Treat; 2020; 19():1533033820935860. PubMed ID: 32588760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction and Verification of a Hypoxia-Related 4-lncRNA Model for Prediction of Breast Cancer.
    Zhao Y; Liu L; Zhao J; Du X; Yu Q; Wu J; Wang B; Ou R
    Int J Gen Med; 2021; 14():4605-4617. PubMed ID: 34429643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Landscape of Iron Metabolism-Related and Methylated Genes in the Prognosis Prediction of Clear Cell Renal Cell Carcinoma.
    Mou Y; Zhang Y; Wu J; Hu B; Zhang C; Duan C; Li B
    Front Oncol; 2020; 10():788. PubMed ID: 32528886
    [No Abstract]   [Full Text] [Related]  

  • 30. Genome-wide screening and cohorts validation identifying novel lncRNAs as prognostic biomarkers for clear cell renal cell carcinoma.
    Zhang C; Huang D; Liu A; Xu Y; Na R; Xu D
    J Cell Biochem; 2020 Mar; 121(3):2559-2570. PubMed ID: 31646670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Cuproptosis-Related Gene Model For Predicting the Prognosis of Clear Cell Renal Cell Carcinoma.
    Mei W; Liu X; Jia X; Jin L; Xin S; Sun X; Zhang J; Zhang B; Chen Y; Che J; Ma W; Ye L
    Front Genet; 2022; 13():905518. PubMed ID: 36092880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Bioinformatic Analysis of Immune-Related Prognostic Genes in Clear Cell Renal Cell Carcinoma Based on TCGA and GEO Databases.
    Li J; Cao J; Li P; Deng R; Yao Z; Ying L; Tian J
    Int J Gen Med; 2022; 15():325-342. PubMed ID: 35035230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive analysis of new prognostic signature based on ferroptosis-related genes in clear cell renal cell carcinoma.
    Zheng B; Niu Z; Si S; Zhao G; Wang J; Yao Z; Cheng F; He W
    Aging (Albany NY); 2021 Aug; 13(15):19789-19804. PubMed ID: 34370716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated analysis on the N6-methyladenosine-related long noncoding RNAs prognostic signature, immune checkpoints, and immune cell infiltration in clear cell renal cell carcinoma.
    Qiu Y; Wang X; Fan Z; Zhan S; Jiang X; Huang J
    Immun Inflamm Dis; 2021 Dec; 9(4):1596-1612. PubMed ID: 34432955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery and construction of prognostic model for clear cell renal cell carcinoma based on single-cell and bulk transcriptome analysis.
    Zhang F; Yu S; Wu P; Liu L; Wei D; Li S
    Transl Androl Urol; 2021 Sep; 10(9):3540-3554. PubMed ID: 34733651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma.
    Wu Z; Shen Y; Fan D; Liu J; Chen D; Wang K; Xu X
    Int Immunopharmacol; 2021 Jan; 90():107119. PubMed ID: 33243605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma.
    Wang Y; Cong R; Liu S; Zhu B; Wang X; Xing Q
    Cancer Cell Int; 2021 Jan; 21(1):46. PubMed ID: 33430867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data.
    Zeng JH; Lu W; Liang L; Chen G; Lan HH; Liang XY; Zhu X
    J Transl Med; 2019 Aug; 17(1):281. PubMed ID: 31443717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Excavation of diagnostic biomarkers and construction of prognostic model for clear cell renal cell carcinoma based on urine proteomics.
    Yang Y; Pang Q; Hua M; Huangfu Z; Yan R; Liu W; Zhang W; Shi X; Xu Y; Shi J
    Front Oncol; 2023; 13():1170567. PubMed ID: 37260987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.